|
Market Closed -
Nasdaq
16:00:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.2831 USD | -2.81% |
|
-14.29% | -90.10% |
| 09-16 | Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma | FI |
| 09-15 | Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMM | Delayed | |
OTC Markets
| PRRU.F | Delayed | |
|
Deutsche Boerse AG
| YP1B | Delayed | |
|
Tradegate
| YP1B | Real-time | |
|
Börse Stuttgart
| YP1B | Delayed | |
|
Boerse Muenchen
| YP1B | Real-time | |
Nasdaq
| IMMP | Delayed | |
|
CBOE
| IMMP | Real-time | |
|
Deutsche Boerse AG
| YP1A | Delayed | |
|
Tradegate
| YP1A | Real-time | |
|
Börse Stuttgart
| YP1A | Delayed | |
|
Boerse Muenchen
| YP1A | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.35 | 0.4035 | 1.01 |
| Spread/Res. | -19.11% | -29.84% | -71.97% |
| Spread/Supp. | +12.65% | +33.47% | +128.31% |
| Support | 0.2513 | 0.2121 | 0.124 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Charts Immutep Limited
Select your edition
All financial news and data tailored to specific country editions
